EHR

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

Investor webinar scheduled Tuesday, January 28, 2025, at 8:00 AM ESTMIAMI, Jan. 23, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS),…

12 months ago

The Hemp Doctor Unveils Solventless THCA Bubble Hash in Seven Strains

MOORESVILLE, N.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor is thrilled to introduce its latest THCA innovation: THCA…

12 months ago

Apps Associates Introduces AppsAccelerate for Healthcare to Enhance Healthcare Operations and Insights

Empowering healthcare providers with Oracle Cloud’s advanced analytics and planning capabilities to optimize operations, enhance patient care, and drive efficiency.ACTON,…

12 months ago

MEDITECH Shares Strategies for Interconnected Care and Meaningful Data Exchange at ViVE 2025

Visit booth #2126 to learn how Expanse’s innovative technology promotes a holistic, intelligent approach to healthcare.CANTON, Mass.--(BUSINESS WIRE)--Discover what makes…

12 months ago

DeepScribe and Flatiron Health Announce Partnership To Bring Oncology-Specific Ambient AI to Flatiron’s 4,200+ Providers

DeepScribe to be the first ambient AI partner for Flatiron Health, integrating with their OncoEMR® to automatically document the complexities…

12 months ago

Driving Innovation Through Diversity, Equity, and Inclusion: Insights From Black Book Research’s 2025 Study on Healthcare IT

Black Book Research Shares Key Insights and Recognizes Top 21 Vendors Advancing Diversity, Equity, and Inclusion TAMPA, FLORIDA / ACCESS…

12 months ago

Streamline Health® Announces Fourth CommunityWorks RevID Contract With Kentucky-Based Health System

Oracle Health partnership enables 120-bed Kentucky-based health system to leverage RevID’s automated charge reconciliation to improve financial performanceATLANTA, Jan. 22,…

12 months ago

Coloplast A/S – Q1 2024/25 Earnings Release – Invitation to conference call on 4 February 2025 at 11.00am CET (correction)

Tuesday, 4 February 2025 at 11.00 - 12.00am CET (corrected from 10.00 - 11.00am CET in an earlier version of…

12 months ago

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

PANProfiler Colon achieved 92.69% positive and 94.05% negative agreement for MSI/dMMR detection Real-world blinded validation on 3178 colorectal cancer patient samplesData…

12 months ago